Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 41 of the 42 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
OBJECTIVE—The effectiveness of intentional weight loss in reducing cardiovascular disease (CVD) events in type 2 diabetes is unknown. This report describes 1-year changes in CVD risk factors in a trial designed to examine the long-term effects of an intensive lifestyle intervention on the incidence of major CVD events. RESEARCH DESIGN AND METHODS—This study consisted of a multicentered, randomized, controlled trial of 5,145 individuals with type 2 diabetes, aged 45–74 years, with BMI >25 kg/m2 (>27 kg/m2 if taking insulin). An intensive lifestyle intervention (ILI) involving group and individual meetings to achieve and maintain weight loss through decreased caloric intake and increased physical activity was compared with a diabetes support and education (DSE) condition. RESULTS—Participants assigned to ILI lost an average 8.6% of their initial weight vs. 0.7% in DSE group (P < 0.001). Mean fitness increased in ILI by 20.9 vs. 5.8% in DSE (P < 0.001). A greater proportion of ILI participants had reductions in diabetes, hypertension, and lipid-lowering medicines. Mean A1C dropped from 7.3 to 6.6% in ILI (P < 0.001) vs. from 7.3 to 7.2% in DSE. Systolic and diastolic pressure, triglycerides, HDL cholesterol, and urine albumin-to-creatinine ratio improved significantly more in ILI than DSE participants (all P < 0.01). CONCLUSIONS—At 1 year, ILI resulted in clinically significant weight loss in people with type 2 diabetes. This was associated with improved diabetes control and CVD risk factors and reduced medicine use in ILI versus DSE. Continued intervention and follow-up will determine whether these changes are maintained and will reduce CVD risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight-loss specific behaviors associated with long term success include: frequent self-monitoring and self-weighing, reduced calorie intake, smaller and more frequent meals/snacks throughout the day, increased physical activity, consistently eating breakfast, more frequent at-home meals compared with restaurant and fast-food meals, reducing screen time, and use of portion-controlled meals or meal”
From Maintenance of Lost Weight and Long-Term Management of Obesity (2018) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Regarding whole foods, multiple meal patterns have been shown to be advantageous for the management of DM, which promote reductions in glycemia, BP, and CVD risk factors.679,901,920–924”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [922]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“previously studied interventions elicited 4–9% weight loss in patients with T2D [25, 26]”
From Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study (2018) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HbA1c reductions up to 7 mmol mol−1 (0.6%) via intensive lifestyle intervention [25] and 11 mmol mol−1 (1.0%) via an energy-restricted low-carbohydrate diet with partial food provision delivered via an outpatient setting [26] were previously reported.”
From Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study (2018) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the Look AHEAD (Action for Health in Diabetes) study, intensive lifestyle participants exhibited greater decreases in triglycerides and increases in HDL cholesterol than the control group, while both the intensive lifestyle and usual care groups decreased LDL cholesterol ( 218 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [218]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Cited by
Items 801–900 of 1,000
Chung, S., Zhao, B., Lauderdale, D. S., Linde, R. B., Stafford, R. S., & Palaniappan, L. P. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2014.04.005 · Cited by 14
“Even in the pre-diabetic stage, initiation of lifestyle changes and medications are beneficial [4–8].”
BackgroundKenkre, J. S., Tan, T., & Bloom, S. R. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.5 · Cited by 17
Contemporary strategies for weight loss and cardiovascular disease risk factor modification
Hill, A. M., & Kris‐Etherton, P. M. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0076-1 · Cited by 16
Management of diabetes across the course of disease: minimizing obesity-associated complications
Apovian, C. M. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s24022 · Cited by 14
[OBESITY MANAGEMENT IN THE PRIMARY CARE SETTING BY AN INTENSIVE LIFESTYLE INTERVENTION].
Armenta-Guirado, B. I., Díaz-Zavala, R. G., Juillerat, M. E. V., & Plata, T. Q. (2015) · PubMed · doi:10.3305/nh.2015.32.4.9366 · Cited by 19
Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus.
Onge, E. S., Miller, S. A., & Clements, E. A. (2012) · PubMed · Cited by 33
Commercial Programs' Online Weight‐Loss Claims Compared to Results from Randomized Controlled Trials
Vakil, R. M., Chaudhry, Z. W., Doshi, R. S., Clark, J. M., & Gudzune, K. A. (2017) · Obesity · doi:10.1002/oby.21959 · Cited by 15
Zaki, N. A. M., Appannah, G., Nor, N. S. M., Omar, A., Mansor, F., Ambak, R., Mohsin, S. S., & Aris, T. (2018) · BMC Women s Health · doi:10.1186/s12905-018-0595-z · Cited by 15
End‐of‐Trial Health Outcomes in Look AHEAD Participants who Elected to have Bariatric Surgery
Wadden, T. A., Chao, A. M., Bahnson, J. L., Bantle, J. P., Clark, J. M., Gaussoin, S. A., Jakicic, J. M., Johnson, K., Miller, G. D., Unick, J. L., et al. (2019) · Obesity · doi:10.1002/oby.22411 · Cited by 14
“) Fasting blood samples were collected and assayed for hemoglobin A1c (HbA1c), triglycerides, and other values described previously (23).”
MethodSaiki, A., Kanai, R., Nakamura, S., Tanaka, S., Oka, R., Watanabe, Y., Yamaguchi, T., Ohira, M., Oshiro, T., Hayashi, K., et al. (2020) · Obesity Facts · doi:10.1159/000509342 · Cited by 16
Tang, J. W., Freed, B. H., Baker, T., Kleczek, J., Tartaglia, K. M., Laiteerapong, N., Press, V. G., Schwartz, M., & Arora, V. M. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-1084-8 · Cited by 14
Weber, P., Thomsen, M. N., Skytte, M. J., Samkani, A., Carl, M. H., Astrup, A. V., Frystyk, J., Holst, J. J., Hartmann, B., Madsbad, S., et al. (2022) · Nutrients · doi:10.3390/nu14245244 · Cited by 13
Unick, J. L., Pellegrini, C. A., DUNSIGER, S. I., Demos, K. E., Thomas, J. G., Bond, D. S., Lee, R. H., Webster, J., & Wing, R. R. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.14587 · Cited by 14
Missing the Target: A Scoping Review of the Use of Percent Weight Loss for Obesity Management
Sherifali, D., Racey, M., Fitzpatrick‐Lewis, D., Greenway, M., Sockalingam, S., Wada, J., Teoh, S. H., Patton, I. T., Macklin, D., van Rossum, E. F. C., et al. (2025) · Obesity Reviews · doi:10.1111/obr.13960 · Cited by 13
“The majority of the included studies refer back to the DPP [14], Look AHEAD [13], or the DiRECT trial [15] (see Appendix S2 for details of these interventions) to support the reason or rationale for setting the percentage body weight goal of their study and the health benefit/outcome linked to that…”
InfluentialHuelgas, R. G., Peralta, F. G., Fernández, L. C., Galve, E., Casanueva, F. F., Puig‐Domingo, M., Bravo, J. J. M., Orozco‐Beltrán, D., Muñoz, J. E., Torre, E. L. M., et al. (2015) · Revista Clínica Española · doi:10.1016/j.rce.2015.07.003 · Cited by 21
Paravattil, B., Wilby, K. J., & Turgeon, R. D. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.02.002 · Cited by 13
A 2.5-Year Weight Management Program Using Noom Health: Protocol for a Randomized Controlled Trial
Sysko, R., Bibeau, J., Boyar, A., Costello, K., Michaelides, A. P., Mitchell, E. S., Susanin, A., & Hildebrandt, T. (2022) · JMIR Research Protocols · doi:10.2196/37541 · Cited by 14
Ferdinand, K. C., Dunn, J. P., Nicolay, C., Sam, F., Blue, E. K., & Wang, H. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01775-x · Cited by 14
“7% in the standard diabetes education arm, concurrent with a 7-mmHg decrease in SBP [43].”
BackgroundSchwartz, S. S., Fabricatore, A. N., & Diamond, A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_31 · Cited by 17
Gage, D. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2270 · Cited by 13
Goodrich, D. E., Buis, L. R., Janney, A. W., Ditty, M. D., Krause, C. W., Zheng, K., Sen, A., Strecher, V. J., Hess, M. L., Piette, J. D., et al. (2011) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-11-47 · Cited by 15
“Moderate-intensity physical activity such as walking can reduce the risk of developing chronic diseases, particularly among individuals at high risk for type 2 diabetes and cardiovascular disease [5-10].”
BackgroundProeschold‐Bell, R. J., Steinberg, D., Yao, J., Eagle, D. E., Smith, T. W., Cai, G. Y., & Turner, E. L. (2018) · Translational Behavioral Medicine · doi:10.1093/tbm/iby117 · Cited by 13
Factors associated with early non‐response within an Internet‐based behavioural weight loss program
Unick, J. L., Ross, K. M., & Wing, R. R. (2019) · Obesity Science & Practice · doi:10.1002/osp4.341 · Cited by 15
“In addition, participants were instructed to log into the study website each week to view a 10- to 15-min multimedia lesson which focused on standard behavioural WL strategies and was modelled after the intervention provided within the Look AHEAD trial (20).”
MethodOverview of Exercise Prescription for Diabetes Patients and Its Application in Japan
Sato, Y. (2020) · Journal of Science in Sport and Exercise · doi:10.1007/s42978-020-00061-6 · Cited by 18
Severe hypoglycemia in the Look AHEAD Trial
Greenway, F. L. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.03.016 · Cited by 13
Sitting Time, Type, and Context Among Long-Term Weight-Loss Maintainers
Roake, J., Phelan, S., Alarcon, N., Keadle, S. K., Rethorst, C. D., & Foster, G. D. (2021) · Obesity · doi:10.1002/oby.23148 · Cited by 12
“1 kg) criterion was selected to approximate a clinically significant 10% weight loss (15), assuming a 200lb (90 kg) starting weight among people entering WW and other weight- loss programs (17,18).”
BackgroundPantalone, K. M., Xiao, H., Bena, J., Morrison, S. M., Downie, S., Boyd, A., Shah, L., Willis, B., Beharry-Diaz, J., Milinovich, A., et al. (2025) · NEJM Catalyst · doi:10.1056/cat.25.0016 · Cited by 17
Rav-Marathe, K., Wan, T. T. H., & Marathe, S. (2016) · Journal of Integrated Design and Process Science · doi:10.3233/jid-2016-0010 · Cited by 13
“A randomized controlled trial with more than 5,000 Type 2 diabetics conducted by Pi-Sunyer et al. (2007) showed that weight loss through reduced food intake and increased physical activity complemented a medication regimen so that patients had better clinical outcomes and needed less medication to…”
Patel, M. L., Cleare, A. E., Smith, C. M., Rosas, L. G., & King, A. C. (2022) · JMIR Formative Research · doi:10.2196/42191 · Cited by 15
Fitness, Fatness, and Cardiovascular Disease Risk and Outcomes
Jakicic, J. M., Mishler, A. E., & Rogers, R. J. (2011) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-011-0158-4 · Cited by 14
Spencer, L., O'Shea, M., Ball, L., Desbrow, B., & LEVERITT, M. D. (2013) · Australian Journal of Primary Health · doi:10.1071/py13021 · Cited by 12
Bishay, R. H., Omari, A., Zang, J., Lih, A., & Kormas, N. (2013) · Clinical Diabetes · doi:10.2337/diaclin.31.1.14 · Cited by 12
Krukowski, R. A., DiLillo, V. G., Ingle, K., Harvey, J. R., & West, D. S. (2016) · JMIR Research Protocols · doi:10.2196/resprot.5382 · Cited by 12
“Fortunately, evidence-based lifestyle weight control programs have been shown to produce clinically significant weight losses, with studies reporting average weight losses of 7%-9% [2,3], a magnitude of weight reduction that confers substantial health benefits [4].”
BackgroundLiss, D. T., Finch, E. A., Cooper, A., Sheth, A., Tejuosho, A. D., Lancki, N., & Ackermann, R. T. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.030 · Cited by 13
“In the past decade, the Look AHEAD efficacy trial demonstrated that adherence to resourceintensive lifestyle interventions results in meaningful weight loss, improved cardiovascular risk factor levels and less need for medications for patients carefully selected in academic medical settings [9].”
BackgroundResultInfluentialBoutelle, K. N., Eichen, D. M., Peterson, C. B., Strong, D. R., Rock, C. L., & Marcus, B. H. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.105824 · Cited by 13
Weight Loss Interventions and Skeletal Health in Persons with Diabetes
Zhao, Q., Khedkar, S. V., & Johnson, K. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00744-9 · Cited by 13
Stylopoulos, N., & Aguirre, V. (2009) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.01.022 · Cited by 12
Managing Highly Insulin-Resistant Diabetes Mellitus: Weight Loss Approaches and Medical Management
Brown, A., Desai, M., Taneja, D., & Tannock, L. R. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.01.2110 · Cited by 12
“Results after 1 year revealed a statistically signifi cant weight loss in ILI in all subsets of a demographically and ethnically diverse population.(23) Participants’ weight loss was strongly correlated with their adherence to the treatment recommendations.”
BackgroundManagement of Obesity in Adults
SKOLNIK, N., & Ryan, D. H. (2014) · Cited by 12
Inada, S., Yoshiuchi, K., Iizuka, Y., Ohashi, K., Kikuchi, H., Yamamoto, Y., Kadowaki, T., & Akabayashi, A. (2016) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9535-1 · Cited by 14
Fahey, M. C., Talcott, G. W., Bauer, C. M. C., Bursac, Z., Gladney, L. A., Hare, M. E., Harvey, J. R., Little, M. A., McCullough, D., Hryshko‐Mullen, A., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.09.012 · Cited by 13
Tuccinardi, D., Giorgino, R., Pieralice, S., Watanabe, M., Maggi, D., Palermo, A., Defeudis, G., Fioriti, E., Pozzilli, P., & Manfrini, S. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01634-1 · Cited by 13
Jiménez‐García, R., Hernández‐Barrera, V., Jiménez‐Trujillo, I., Carrasco‐Garrido, P., López‐de‐Andrés, A., & de Miguel, Á. G. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.06.002 · Cited by 12
Apolzan, J. W., LaRose, J. G., Anton, S. D., Beyl, R. A., Greenway, F. L., Wickham, E. P., Lanoye, A. M., Harris, M. N., Martin, C. K., Bullard, T., et al. (2023) · Nutrition and Diabetes · doi:10.1038/s41387-023-00234-6 · Cited by 13
“5% greater reduction in hemoglobin A1c (HbA1c) than did a usual care approach at 1 year [5].”
BackgroundMethodAstbury, N. M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15855 · Cited by 12
The effects of supervised aerobic training on dyslipidaemia among diabetic older patients
Alghadir, A. H., Gabr, S. A., & Iqbal, A. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01745-8 · Cited by 13
Chouk, K., Triki, R., Dergaa, I., Ceylan, H. İ., Bougrine, H., Muntean, R. I., & Abderrahman, A. B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1525559 · Cited by 12
Canagliflozin for the treatment of adults with Type 2 diabetes
Meininger, G. E., Canovatchel, W. J., Polidori, D., & Rosenthal, N. (2015) · Diabetes Management · doi:10.2217/dmt.15.11 · Cited by 11
Rothstein, R. I., Kopjar, B., Woodman, G. E., Swain, J. M., de la Cruz-Muñoz, N., Kushnir, V. M., Pryor, A. D., English, W. J., Odstrcil, E. A., & Sullivan, S. (2024) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2023.10.002 · Cited by 11
Belalcazar, L. M., Papandonatos, G. D., McCaffery, J. M., Peter, I., Pajewski, N. M., Erar, B., Palmer, N. D., Balasubramanyam, A., Bowden, D. W., Brautbar, A., et al. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00109.2014 · Cited by 12
Azadbakht, L., Haghighatdoost, F., Karimi, G., & Esmaillzadeh, A. (2012) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2012.753039 · Cited by 11
Huang, J., Cheng, F., Tsai, L., Lee, N., & Lu, Y. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12164 · Cited by 15
Meal replacements as a strategy for weight loss in obese hemodialysis patients
Lassemillante, A. M., Oliver, V., Hickman, I. J., Murray, E., & Campbell, K. L. (2016) · Hemodialysis International · doi:10.1111/hdi.12419 · Cited by 11
Type 2 Diabetes Treatment in the Patient with Obesity
Malin, S. K., & Kashyap, S. R. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.04.007 · Cited by 15
Achievement of Guideline-Recommended Weight Loss Among Patients With Ischemic Stroke and Obesity
Dearborn, J. L., Viscoli, C. M., Young, L. H., Gorman, M., Furie, K. L., & Kernan, W. N. (2019) · Stroke · doi:10.1161/strokeaha.118.024008 · Cited by 11
Omura, Y., Murakami, K., Matoba, K., Nishimura, R., & Sasaki, S. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.11.006 · Cited by 12
Taylor, R. (2011) · Practical Diabetes · doi:10.1002/pdi.1639 · Cited by 11
Linking diabetes and atherosclerosis
Candido, R., Bernardi, S., & Allen, T. J. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.46 · Cited by 13
Cho, E.-Y., Kemmet, O., & Frenken, M. (2011) · Obesity Facts · doi:10.1159/000327037 · Cited by 11
Boo, S. (2013) · Asian Nursing Research · doi:10.1016/j.anr.2013.09.003 · Cited by 16
“Weight loss can favorably reduce the risk for such diseases (Hamman et al., 2006; Pi-Sunyer et al., 2007).”
BackgroundBelalcazar, L. M., Anderson, A., Lang, W., Schwenke, D. C., Haffner, S. M., Yatsuya, H., Rushing, J., Vitolins, M. Z., Reeves, R., Pi-Sunyer, X., et al. (2014) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.06.357 · Cited by 11
Richey, P. A., Johnson, K., Neiberg, R. H., Bahnson, J. L., Singhal, K., Coday, M., Thomas, F., Lewis, C. E., & Mihalko, W. M. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.01.057 · Cited by 11
LaRose, J. G., Leahey, T. M., Lanoye, A. M., Reading, J. M., & Wing, R. R. (2020) · Obesity · doi:10.1002/oby.22797 · Cited by 11
Dalmazi, G. D., Coluzzi, S., BALDASSARRE, M. P. A., Sorbo, S. E., Dell’Aquila, S., Febo, F., Ginestra, F., Graziano, G., Rossi, M. C., Consoli, A., et al. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.07.002 · Cited by 11
Data-analytically derived flexible HbA1c thresholds for type 2 diabetes mellitus diagnostic
Stranieri, A., Yatsko, A., Jelinek, H. F., & Venkatraman, S. (2015) · Artificial Intelligence Research · doi:10.5430/air.v5n1p111 · Cited by 13
“[44] A targeted study of the impact of lifestyle changes involving a number of clinical sites across the US, where one half of participants were required to fulfil dieting and modest physical activity recommendations, and another half was simply educated about the benefits of diet and exercise, has shown a dramatic im…”
BackgroundInfluentialObesity and Cardiovascular Disease
Poirier, P. (2006) · Circulation · doi:10.1161/circulationaha.106.646455 · Cited by 13
Sonomtseren, S., Sankhuu, Y., Warfel, J. D., Johannsen, D. L., Peterson, C. M., & Vandanmagsar, B. (2016) · Obesity Science & Practice · doi:10.1002/osp4.56 · Cited by 10
Corbin, K. D., IGUDESMAN, D. A., Addala, A., Casu, A., Crandell, J., Kosorok, M. R., Maahs, D. M., Pokaprakarn, T., Pratley, R. E., Souris, K. J., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106765 · Cited by 10
Terapia Nutricional no Pré-Diabetes e no Diabetes Mellitus Tipo 2
Ramos, S., Campos, L. F., Baptista, D. R., Strufaldi, M. B., Gomes, D. L., Guimarães, D. B., Souto, D. L., Marques, M., Sousa, S. S. D. S., & de Campos, T. F. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-25 · Cited by 13
Pérez-Muñoz, A., Hare, M. E., Andres, A., Klesges, R. C., Talcott, G. W., Little, M. A., Waters, T. M., Harvey, J. R., Bursac, Z., & Krukowski, R. A. (2023) · Annals of Behavioral Medicine · doi:10.1093/abm/kaad014 · Cited by 10
New Insights in the Prevention and Early Management of Type 2 Diabetes
Lau, D. C. W. (2011) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(11)53002-3 · Cited by 10
Weight Change, Blood Pressure, Lipids and Glycemic Control among Patients with Type 2 Diabetes
Janghorbani, M., Amini, M., & Salehi‐Marzijarani, M. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000327912 · Cited by 10
Audelin, M. C., Savage, P. D., Toth, M. J., Harvey‐Berino, J., Schneider, D. J., Bunn, J. Y., Ludlow, M., & Ades, P. A. (2011) · Metabolism · doi:10.1016/j.metabol.2011.10.001 · Cited by 12
A Review of Risk Factors and Cardiovascular Disease in Diabetes Care - 2011
Nilsson, P. M., & Cederholm, J. (2011) · European Journal of Cardiovascular Medicine · doi:10.5083/ejcm.20424884.43 · Cited by 11
Charles, M., Simmons, R. K., Williams, K. M., Roglić, G., Sharp, S. J., Kinmonth, A., Wareham, N. J., & Griffin, S. J. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x649070 · Cited by 11
Gjevestad, E. S., Karlsen, T., Røislien, J., Mæhlum, S., & Hjelmesaeth, J. S. (2013) · Clinical Obesity · doi:10.1111/cob.12011 · Cited by 11
“Our results, which show that in the ILI group, 48% of patients achieved more than 10% weight loss, are comparable with 1-year data from the Look Ahead trial (10), where 38% of the participants in the ILI group achieved more than 10% weight loss.”
ResultMetabolic Outcomes 1 Year after Gastric Bypass Surgery in Obese People with Type 2 Diabetes
Demssie, Y. N., Jawaheer, J., Farook, S., New, J. P., & Syed, A. A. (2011) · Medical Principles and Practice · doi:10.1159/000331793 · Cited by 10
Effects of a self-management educational program on metabolic control in type 2 diabetes
Sadeghian, H. A., Madhu, S. V., Agrawal, K., KANNAN, A. T., & Agrawal, K. (2016) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1501-115 · Cited by 10
Boonyavarakul, A., Leelawattana, R., Pongchaiyakul, C., Buranapin, S., Phanachet, P., & Pramyothin, P. (2018) · Nutrition and Health · doi:10.1177/0260106018800074 · Cited by 10
Shirai, K., Tanaka, M., Fujita, T., Fujii, Y., Shimomasuda, M., Sakai, S., & Samukawa, Y. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0822-x · Cited by 10
Jalilian, H., Pezeshki, M. Z., Janati, A., Najafipour, F., Sarbakhsh, P., & Zarnaq, R. K. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.052 · Cited by 10
Smith, K. E., Mason, T. B., Schumacher, L. M., Pellegrini, C. A., Goldschmidt, A. B., & Unick, J. L. (2021) · Psychology of sport and exercise · doi:10.1016/j.psychsport.2021.102056 · Cited by 10
McCaffery, J. M., Jablonski, K. A., Pan, Q., Astrup, A. V., Christiansen, M. R., Corella, D., Corso, L. M. L., Florez, J. C., Franks, P. W., Gardner, C. D., et al. (2022) · Diabetes · doi:10.2337/db21-0741 · Cited by 10
de Cuevillas, B., Riezu‐Boj, J. I., Abete, I., Zulet, M. Á., Galarregui, C., González-Navarro, C. J., Milagro, F. I., Martínez, J. A., & Navas‐Carretero, S. (2022) · Nutrition · doi:10.1016/j.nut.2022.111841 · Cited by 10
A new era in gut hormone-based pharmacotherapy for people with obesity
Firman, C., & Batterham, R. L. (2022) · Proceedings of The Nutrition Society · doi:10.1017/s0029665122002695 · Cited by 10
“Lifestyle intervention is the cornerstone for all weight management strategies and weight loss of 5-10% reduces the risk of developing T2D (26) and leads to improvement in some comorbidities such as non-alcoholic fatty liver disease (27) and hypertension (28) .”
BackgroundPariser, G. L., DeMeuro, M. A., Gillette, P. D., & Winters, S. J. (2010) · Cardiopulmonary Physical Therapy Journal · doi:10.1097/01823246-201021020-00002 · Cited by 14
Preoperative Weight Loss in the Context of a Comprehensive Lifestyle Intervention
Kalarchian, M. A., & Marcus, M. D. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9995-3 · Cited by 10
HEALS Hypertension Control Program: Training Church Members as Program Leaders
Dodani, S., Beayler, I., Lewis, J., & Sowders, L. A. (2014) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401408010121 · Cited by 10
Franks, P. W., Huang, T. T. ‐., & Ball, G. D. C. (2007) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(07)13011-2 · Cited by 11
Bariatric surgery: An IDF statement for obese Type 2 diabetes
Dixon, J. B., Zimmet, P., Alberti, K. G. M. M., & Rubino, F. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.07.002 · Cited by 11
Martínez, J. J. G. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.09.007 · Cited by 12
Irvin, V. L., & Kaplan, R. M. (2015) · Annals of Behavioral Medicine · doi:10.1007/s12160-015-9739-7 · Cited by 11
“%) applied a measure that met the Table 1 Selected trial details of the 38 included behavioral interventions Trial Intervention Comparator Intervention length (intensive/full) Participant description N size intervention N size comparator ACT [22] Exercise Brief provider advice 24 months/ 24 months Inactive adults (wom…”
BackgroundInfluentialSherman, L. D., & Fawole, T. (2016) · American Journal of Men s Health · doi:10.1177/1557988316642274 · Cited by 10
Mukherjee, J., Sternhufvud, C., Smith, N., Bell, K. F., Stott‐Miller, M., McMorrow, D., & Johnston, S. S. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.5.449 · Cited by 10
Recomendaciones para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2
Torre, E. L. M., Tejedor, F. J. L., Menéndez, S. A., Núñez-Cortés, J. M., Garcia, A. A., Puig‐Domingo, M., Soláns, J. R. G., Guisasola, F. Á., Alegría, J. G., Bravo, J. J. M., et al. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.07.005 · Cited by 16
Zucatti, A. T. N., de Paula, T. P., Viana, L. V., Dall’Agnol, R. T., Cureau, F. V., de Azevedo, M. J., Gross, J. L., Schaan, B. D., & Leitão, C. B. (2017) · Journal of Diabetes Research · doi:10.1155/2017/6232674 · Cited by 11
“A home-based gradual physical activity program, designed to achieve a goal of 175min of moderate intensity physical activity per week, was evaluated with other lifestyle changes as a cointervention [10] and found to reduce BP (systolic: −4.”
MethodAkins, P. T., Inacio, M. C. S., Bernbeck, J. A., Harris, J., Chen, Y. X., Prentice, H. A., & Guppy, K. H. (2017) · Spine · doi:10.1097/brs.0000000000002456 · Cited by 10
Barnes, R. D., Ivezaj, V., Pittman, B. P., & Grilo, C. M. (2018) · International Journal of Eating Disorders · doi:10.1002/eat.22860 · Cited by 12
“Once enrolled, individuals’ response to weight loss treatments also varies widely, with reported average weight losses obscuring considerable differences (Look Ahead Research Group, 2007).”
Furthering Precision Medicine Genomics With Healthy Living Medicine
Standley, R. A., & Vega, R. B. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.12.009 · Cited by 11
Obesity Primer for the Practicing Gastroenterologist
Jirapinyo, P., & Thompson, C. C. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001200 · Cited by 12
“also experienced significantly greater improvement in HbA1c and several measures of cardiovascular diseases (56,57).”
Background
Metadata
- Authors
- The Look AHEAD Research Group
- Affiliations
- Wake Forest University Health Sciences (US)
- Corresponding author
- The Look AHEAD Research Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-06-01
- Volume
- 30
- Issue
- 6
- Pages
- 1374-1383
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2665929
- OpenAlex
- W1554005703
- Semantic Scholar
- 14760a9ef6a15771653d7c092ab651c008e76eaf
- Cited by
- 1,522
- References
- 41
- Citations by year
- 2026: 22 · 2025: 45 · 2024: 30 · 2023: 48 · 2022: 51 · 2021: 59 · 2020: 54 · 2019: 67 · 2018: 72 · 2017: 82 · 2016: 97 · 2015: 119 · 2014: 100 · 2013: 116 · 2012: 120
- FWCI
- 72.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p30dk046204-15)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-57171, DK 57136, DK57149, DK 57002, DK57182, DK56990, (DK 046204, DK57008, DK57177, DK 57078, DK57219, U01DK057149, DK-57178, U01DK057151, U01DK057135, U01DK057131, U01DK056990, DK-57135, U01DK057136, DK-56992, DK57154, U01DK057178, U01DK057182, U01DK057078, U01DK057154, U01DK057008, U01DK057171, DK57131, U01DK057002, U01DK057219, U01DK056992, U01DK057177, P30DK048520, P30DK040561, DK 57151, P30-DK046204)
- National Center for Research Resources (M01-RR-0021140, M01RR002719, M01RR000056, M01RR000051, M01RR001066, M01RR001346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- type 2 diabetes, weight loss, cardiovascular risk factors, intensive lifestyle intervention, diabetes support and education, glycemic control, HbA1c, physical activity, caloric restriction, hypertension, lipid-lowering drugs, albuminuria, medication reduction
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Exercise Test, Follow-Up Studies, Humans, Life Style, Middle Aged, Patient Education as Topic, Physical Fitness, Self Care, Time Factors, Weight Loss, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.